“It is frightening to realize that we are so far removed from a global health problem that we face a common problem (Govt-19) that transcends boundaries to share experiences, promotes good practices and strengthens cooperation,” Yves Coppieters wrote on his Twitter account. Taking Africa as an example, the expert denies “rejected at home”, “slow” vaccines and “rarely visible” masks.
The same story of Emmanuel Andrey, who regrets that more than 4 billion people have not yet been vaccinated: “Because they are poor. Not by choice.”
The neck grip of rich countries
Is it right for experts to express their concerns about this situation?
According to the latest figures released *, 3,442,086,090 people have so far received at least one dose of the vaccine, or 44.1% of the world’s population.
However, there are gaps in distribution between countries. Thus, “low-income” countries, as the World Bank calls them, were able to vaccinate only 2% of the population over 60% of the rich economies such as Europe, North America or the Emirates. United Arab Emirates.
According to data collected by UNICEF, most countries in sub-Saharan Africa, neighboring East and Central Asia are vaccinated with less than 5% of their population. Even worse, many countries, such as Chad, the Democratic Republic of the Congo or Haiti, have not even reached the 1% of vaccinated citizens.
In the face of such imbalances, the World Health Organization (WHO) boss, Tetros Adanom Capreius, called for a ban on the third dose in early September. Only a small fraction of their population: “I will not remain silent when I think that the companies and countries that control the global distribution of vaccines should be satisfied with the rest of the world’s poor,” he said.
Kovacs, a hit in the water?
The Kovacs organization, set up by the WHO, among others, aims to distribute the quantities evenly around the world. However, it has faced many obstacles, but it seems that the real problem comes from the desire of rich countries to achieve higher vaccine coverage quickly. For this reason, these countries have taken up a large portion of vaccine orders and have passed the equivalent dose distribution.
According to Emmanuel Andre, such actions can have repercussions on the trust placed in managers and large pharmaceutical companies: “Criticism of trust in big drugs and those who rule us swells.”
* Our world in data
“Music geek. Coffee lover. Devoted food scholar. Web buff. Passionate internet guru.”